These Connecticut-based companies made this year's Fortune 500 list with revenue up to $275 billion
Fifteen Connecticut-headquartered companies made the 2026 Fortune 500, with revenues based on prior fiscal years. Cigna (Bloomfield) led at No. 14 with about $274.9 billion revenue. Amazon ranked No. 1 overall with nearly $717 billion. The Fortune 500 totaled about $21 trillion in revenue and $2 trillion in profits in 2025.
How this was made
The 30-second read
Why it matters
Most of the piece is ranking/recap content, but it includes company-specific items for Cigna (leadership transition, layoffs, ACA exchange exit, FTC insulin-PBM settlement), Charter (merger timing), Synchrony (Q4 purchase volume and charge-offs), and Amphenol (acquisition-driven growth).
Market read
Trading relevance is concentrated in the bundled company-specific datapoints (CI regulatory/leadership actions, SYF credit metrics, APH acquisition-driven growth, CHTR merger timing). Pure ranking mentions are likely low incremental impact.
What to watch
Market reaction will depend on whether traders already priced the CI regulatory/leadership items and whether SYF’s charge-off trend is better or worse than consensus expectations—neither is provided here.
Background
The article lists Connecticut-headquartered companies in the 2026 Fortune 500 (based on prior fiscal-year revenues) and adds a short rundown of selected recent developments for several firms.
Ticker impact
Cigna is highlighted as No. 14 in the Fortune 500 with 2025 revenue up ~11%, plus leadership retirement, layoffs, ACA exchange exit, and FTC insulin-PBM settlement details.
Low-to-medium near-term volatility risk; direction unclear without market reaction data.
The piece provides several discrete corporate/regulatory developments for CI, but it does not include new financial guidance or a fresh outcome beyond previously described events.
Charter Communications is listed as No. 85 with 2025 revenue and notes it expects to complete its merger with Cox in 2H 2026.
Potential modest positive bias if traders focus on deal progress; otherwise limited impact.
The article reiterates deal timing and provides customer-count context, but does not add new deal terms or regulatory outcomes.
Philip Morris International is listed as No. 117, with emphasis on its smoke-free strategy (e.g., Zyn) and regulatory/political scrutiny around nicotine pouches.
Limited immediate price impact; longer-horizon risk premium may persist.
No new regulatory ruling, trial result, or enforcement action is provided—only discussion of existing concerns and product strategy.
Amazon is named as Fortune 500 No. 1 overall with 2025 revenue near $717B and operational footprint in Connecticut.
Negligible incremental impact; any move would likely be driven by other AMZN-specific news.
No new Amazon-specific operational, financial, or regulatory event is introduced beyond the ranking and Connecticut employment footprint.
Walmart is mentioned as Fortune 500 No. 2 with 2025 ranking context and its Connecticut store presence.
Negligible incremental impact.
The article does not provide new guidance, deals, or regulatory actions for WMT.
UnitedHealth Group is included in the Fortune 500 top-10 list, but without any company-specific new development.
Negligible incremental impact.
No new UNH event (earnings, guidance, lawsuit, deal) is described.
Apple is listed in the Fortune 500 top-10, but the article provides no Apple-specific new facts beyond ranking context.
Negligible incremental impact.
No new Apple operational/financial/regulatory development is provided.
Alphabet is named in the Fortune 500 top-10 list with no additional Alphabet-specific news.
Negligible incremental impact.
The article does not add any GOOGL-specific catalyst.
Market effects
Health insurers/PBMs face ongoing regulatory scrutiny (CI FTC insulin-PBM settlement) while telecom and consumer credit narratives (CHTR merger progress; SYF charge-offs) remain sentiment-sensitive.
Connecticut corporate footprint is emphasized; limited direct tradable regional effect beyond sector read-through.
Fortune 500 scale recap with limited incremental global macro signal; only CI/PM strategic/regulatory themes have broader policy relevance.
Counterpoint
Treat this primarily as a Fortune 500 recap: most price-relevant catalysts (CI FTC settlement, layoffs, ACA exchange exit, CHTR merger) may already be known, so incremental trading impact could be small.
Key entities
- companyThe Cigna Group
Connecticut-headquartered health insurer/PBM; No. 14 Fortune 500; includes leadership retirement, layoffs, ACA exchange exit, and FTC insulin-PBM settlement details.
- companyCharter Communications
Connecticut-headquartered cable/internet provider; No. 85; expects to complete Cox merger in 2H 2026.
- companySynchrony
Store credit provider; No. 197; includes Q4 2025 purchase volume and net charge-off rate.
- companyAmphenol
Electronic components maker; No. 198; cites acquisition-driven revenue growth.
